News & Updates

Single-dose baloxavir reduces household transmission of influenza

30 Apr 2025 by

A single dose of baloxavir given to an index patient (IP) reduces the odds of influenza transmission to untreated household contacts (HHCs) by 32 percent vs placebo, according to the results of the phase IIIb CENTERSTONE trial.

Single-dose baloxavir reduces household transmission of influenza

30 Apr 2025

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

29 Apr 2025

Clinically relevant drug–drug interactions (DDIs) are highly prevalent among oncohematology patients treated with nirmatrelvir/ritonavir (NMV/r) for COVID-19, reveals a study. Pharmacists have played an important role in detecting, categorizing, and mitigating these DDIs.

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

29 Apr 2025

Nasal microbiome could be aiding COVID-19 infection

27 Apr 2025 by

The presence of certain bacteria in the nose appear to contribute to a more receptive environment for SARS-CoV-2 in the respiratory tract, according to new research.

Nasal microbiome could be aiding COVID-19 infection

27 Apr 2025

SOF/VEL combo improves well-being of children with CHC

27 Apr 2025 by

In children with chronic hepatitis C (CHC), effective treatment with sofosbuvir/velpatasvir (SOF/VEL) results in improvements in certain areas of their well-being at 1 year. This suggests some patient-reported outcomes (PRO) benefits of direct-acting antiviral (DAA) therapy. However, the parents’ proxy reports show a decrease in the patients’ school functioning.

SOF/VEL combo improves well-being of children with CHC

27 Apr 2025

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

27 Apr 2025

In the treatment of children with febrile urinary tract infection (UTI), individualized treatment appears to be associated with reduced antibiotic use and fewer adverse event days as compared with standard 10-day treatment, according to a study.

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

27 Apr 2025

Dengue risk rises with bad air quality, high ambient temperature

26 Apr 2025 by

Higher concentrations of particulate matter and carbon monoxide, coupled with elevated ambient temperatures, appear to be driving an increase in the risk of dengue infections, according to a study from Singapore.

Dengue risk rises with bad air quality, high ambient temperature

26 Apr 2025

Nirsevimab reduces RSV-related outcomes in infants

25 Apr 2025

Immunoprophylaxis with nirsevimab results in a 74-percent decrease in hospitalization and 85-percent reduction in paediatric intensive care unit (PICU) admissions due to respiratory syncytial virus (RSV)-related bronchiolitis, a study has shown.

Nirsevimab reduces RSV-related outcomes in infants

25 Apr 2025

MRSA infection may be detrimental to children with cystic fibrosis

25 Apr 2025

Among children with cystic fibrosis, those who contract methicillin-resistant Staphylococcus aureus (MRSA) infection appear to have worse respiratory outcomes, including increased antibiotic exposure and breathing obstruction, as reported in a retrospective study.

MRSA infection may be detrimental to children with cystic fibrosis

25 Apr 2025

Nirmatrelvir-ritonavir for COVID-19 works in patients with advanced kidney dysfunction

14 Apr 2025

Treatment with nirmatrelvir-ritonavir yields reductions in the risk of acute respiratory failure and pneumonia in COVID-19 patients with advanced kidney function, according to a retrospective matched cohort study.

Nirmatrelvir-ritonavir for COVID-19 works in patients with advanced kidney dysfunction

14 Apr 2025

More infections diagnosed after COVID-19

13 Apr 2025 by

Patients with an acute SARS-CoV-2 infection tend to have a subsequent increase in diagnosed infections over the next 12 months, according to new research.

More infections diagnosed after COVID-19

13 Apr 2025

News & Updates

Filter by Specialty:

Specialty:

Single-dose baloxavir reduces household transmission of influenza

Single-dose baloxavir reduces household transmission of influenza

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

Nasal microbiome could be aiding COVID-19 infection

Nasal microbiome could be aiding COVID-19 infection

SOF/VEL combo improves well-being of children with CHC

SOF/VEL combo improves well-being of children with CHC

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

Dengue risk rises with bad air quality, high ambient temperature

Dengue risk rises with bad air quality, high ambient temperature

Nirsevimab reduces RSV-related outcomes in infants

Nirsevimab reduces RSV-related outcomes in infants

MRSA infection may be detrimental to children with cystic fibrosis

MRSA infection may be detrimental to children with cystic fibrosis

Nirmatrelvir-ritonavir for COVID-19 works in patients with advanced kidney dysfunction

Nirmatrelvir-ritonavir for COVID-19 works in patients with advanced kidney dysfunction

More infections diagnosed after COVID-19

More infections diagnosed after COVID-19